ADCIRCA

Found in: Austria Australia Canada Spain France Lithuania Netherlands United Kingdom United States

Active ingredients

#
Active Ingredient
Description
1

Tadalafil is a selective, reversible inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). When sexual stimulation causes the local release of nitric oxide, inhibition of PDE5 by tadalafil produces increased levels of cGMP in the corpus cavernosum. This results in smooth muscle relaxation and inflow of blood into the penile tissues, thereby producing an erection. Tadalafil has no effect in the absence of sexual stimulation.

Medicine classification

ATC Code
Title
Class
Tadalafil
G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BE Drugs used in erectile dysfunction

Identifiers

Authority
Identifier(s)
FDA, National Drug Code (US)
Identifier(s): 43353-070, 66302-467
Health Products and Food Branch (CA)
Identifier(s): 02338327
Pharmaceutical Benefits Scheme (AU)
Identifier(s): 12150L, 12151M, 1304P, 1308W
Z-Index G-Standaard PRK (NL)
Identifier(s): 68241
Base de données publique des médicaments (FR)
Identifier(s): 63206355
Centro de información online de medicamentos de la AEMPS (ES)
Identifier(s): 08476006
Medicines & Healthcare Products Regulatory Agency (GB)
Identifier(s): 182492
Valstybinė vaistų kontrolės tarnyba (LT)
Identifier(s): 1056532, 1056533